BIFIDOLAB MICROBIOME G
This product contains patented probiotics and sufficient probiotics to promote the proliferation of probiotics
Negotiable Min Order Quantity 1000 Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- T/T
- Production method
- Available,OBM,ODM,OEM
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- health care, probiotics, microbiology
- Category
- Health Care Supplement
Product name | BIFIDOLAB MICROBIOME G | Certification | HACCP , FDA |
---|---|---|---|
Category | Health Care Supplement | Material | - |
Keyword | health care , probiotics , microbiology | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | South Korea | Stock | 1000 |
Supply type | Available,OBM,ODM,OEM | HS code | - |
Product Information
BIFIDOLAB intestinal probiotics is a synbiotic product that helps intestinal peristalsis and improve constipation. This product contains patented probiotics and sufficient probiotics to promote the proliferation of probiotics (3,500mg Fructooligosaccharides), promote the balance of intestinal flora and help defecation.
Suitable for all people, especially for people with irregular eating habits, frequent diarrhea or constipation, and need to improve intestinal function.
* Bifidobacterium bifidum BGN4 BIFIDOLAB patented Bifidobacterium bifidum BGN4, was isolated from the intestines of healthy breastfed infants. This strain has been notificated by US FDA as NDI and GRAS ingredient, and safety has been proved. At the same time, a number of clinical studies have shown that Bifidobacterium bifidum BGN4 can significantly improve and prevent health problems such as dermatitis and eczema, irritable bowel syndrome, ulcerative enteritis and colitis.
*Bifidobacterium longum BORI BIFIDOLAB patented Bifidobacterium longum BORI, was isolated from the intestines of healthy breast-fed infants. This strain has been notificated by US FDA as NDI and GRAS ingredient, and safety has been proved. At the same time, Bifidobacterium longum BORI can effectively inhibit rotavirus, the inhibition rate is as high as 99%, and has been patented by the United States, Japan and South Korea.
*Fructo-oligosaccharides Intake of sufficient Fructo-oligosaccharides can effectively help relieve constipation, cooperate with probiotics, and improve intestinal microecological balance.
- Verified Certificate
-
B2B Trade
Price (FOB) | Negotiable | transportation | Express |
---|---|---|---|
MOQ | 1000 | Leadtime | Negotiable |
Payment Options | T/T | Shipping time | Negotiable |
- President
- Yong Chul, Shin
- Address
- 23-16, Nonggongdanji-gil, Hongcheon-gun, Gangwon-do, Korea
- Product Category
- Baby Food,Health Care Supplement,Nutrition Supplements,Other Foods
- Year Established
- 1999
- No. of Total Employees
- 51-100
- Company introduction
-
BIFIDO Co., Ltd. was found in 1999 to fully utilize science in nutritious and functional food materials for the improvement of human health and well-being. We focus on basic research and product development using probiotics. Among various probiotics, Bifidobacterium is considered to be the most beneficial microorganism for the maintenance of microbial balance in the intestinal tract. Nowadays Bifidobacterium and other lactic bacteria are being applied widely in functional foods. Especially, we are in the leading edge in the development of human-health promoting Bifidobacterium.
Business Area
1. Gut care (Atopic dermatitis, Irritable bowel syndrome, Rheumatoid joint)
2. Oral care (Bad breath, Periodontal)3. Skin care (Nutricosmetics / Bifida Ferment Lysate)
4. Pharmabiotics (BIFIDO Express Flatform)
5. Raw material
- Main Markets
-
China
Russia
Taiwan
- Main Product